![](https://www.malariada.org/wp-content/uploads/2021/09/tobias-fischer-PkbZahEG2Ng-unsplash-1440x374.jpg)
Calibr-Skaggs Institute for Innovative Medicines
Calibr is a division of The Scripps Research Institute and is dedicated to the translation of new therapies from discovery to early clinical trials. The drug discovery portfolio consists of a diverse set of programs to target human diseases using either small molecules, biologics or cell-based therapies. Among the many drug discovery programs for infectious disease, the malaria team is committed to the discovery and development of new small-molecule drugs for the treatment of and/or protection against malaria.
Laboratory Contributions
High-throughput screening, drug discovery, drug development, target identification, chemical biology, medicinal chemistry, long-acting oral/injectables for treatment and prophylaxis.
![](https://www.malariada.org/wp-content/uploads/2021/10/CaseMc_headshot_MalDA.jpg)
Dr. Case McNamara
Director, Infectious Disease
![](https://www.malariada.org/wp-content/uploads/2021/10/Anil_Gupta_04-700x814.jpeg)
Dr. Anil Kumar Gupta
Director of Medicinal Chemistry